This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Baris, D. Articles by Hartge, P. Search for Related Content PubMed PubMed Citation Articles by Baris, D. Articles by Hartge, P.

Blood Levels of Organochlorines before and after Chemotherapy among Non-Hodgkin’s Lymphoma Patients

Divisions of Cancer Epidemiology and Genetics [D. B., N. R., A. M., R. E. T., P. H.] and Clinical Sciences [L. K., W. W.], National Cancer Institute, Bethesda, Maryland 20892-7240

Several small studies suggest a link between environmental exposure to organochlorine compounds and risk of non Hodgkin’s lymphoma (NHL). Because NHL is uncommon, studies of the topic often use a population-based case-control design, in which cases generally are enrolled after treatment has begun. If chemotherapy affects blood levels of organochlorines, exposure will be misclassified and findings distorted. To determine whether chemotherapy alters serum levels of organochlorines in NHL cases, we compared serum samples before and after treatment in 22 cases diagnosed with NHL between March 1994 and August 1995 and enrolled in a clinical trial at the United States National Cancer Institute’s Clinical Center. The time difference between pretreatment and posttreatment samples ranged from 15 to 27 months with an average of 20 months. Laboratory analyses were conducted in blinded pretreatment and posttreatment pairs of the subjects. Pretreatment and posttreatment organochlorine serum levels were compared using Pearson correlation coefficient (r) and paired t test. The pretreatment and posttreatment serum levels were highly correlated for 1,1-dichloro-2,2-bis(p-chlorophenyl)ethylene (DDE) and polychlorinated biphenyls (PCBs) PCB-138, PCB-153, PCB-156, and total PCBs (ranging from 0.78 to 0.93). Serum levels of all of these organochlorines significantly decreased between initiation and completion of chemotherapy, 25% for total PCB (P = 0.0044), 28% for DDE (P = 0.0014), 25% for PCB-138 (P = 0.0053), 27% for PCB-153 (P = 0.0031), and 29% for PCB-156 (P = 0.045). Neither weight change nor lipid change was correlated with changes in chemical levels. There was no association between the length of time between blood draws and changes in chemical levels. Our data raise the possibility that lymphoma treatment depresses serum organochlorine levels.

This article has been cited by other articles:

				T. T. Vo, B. C. Gladen, G. S. Cooper, D. D. Baird, J. L. Daniels, M. D. Gammon, and D. B. Richardson Dichlorodiphenyldichloroethane and Polychlorinated Biphenyls: Intraindividual Changes, Correlations, and Predictors in Healthy Women from the Southeastern United States Cancer Epidemiol. Biomarkers Prev., October 1, 2008; 17(10): 2729 - 2736. [Abstract] [Full Text] [PDF]

				M. L. Biggs, M. D. Davis, D. L. Eaton, N. S. Weiss, D. B. Barr, D. R. Doody, S. Fish, L. L. Needham, C. Chen, and S. M. Schwartz Serum Organochlorine Pesticide Residues and Risk of Testicular Germ Cell Carcinoma: A Population-Based Case-Control Study Cancer Epidemiol. Biomarkers Prev., August 1, 2008; 17(8): 2012 - 2018. [Abstract] [Full Text] [PDF]

				P Cocco, P Brennan, A Ibba, S de Sanjose Llongueras, M Maynadie, A Nieters, N Becker, M G Ennas, M G Tocco, and P Boffetta Plasma polychlorobiphenyl and organochlorine pesticide level and risk of major lymphoma subtypes Occup. Environ. Med., February 1, 2008; 65(2): 132 - 140. [Abstract] [Full Text] [PDF]

				M. S. Wolff, H. A. Anderson, J. A. Britton, and N. Rothman Pharmacokinetic Variability and Modern Epidemiology The Example of Dichlorodiphenyltrichloroethane, Body Mass Index, and Birth Cohort Cancer Epidemiol. Biomarkers Prev., October 1, 2007; 16(10): 1925 - 1930. [Full Text] [PDF]

				L. S. Engel, F. Laden, A. Andersen, P. T. Strickland, A. Blair, L. L. Needham, D. B. Barr, M. S. Wolff, K. Helzlsouer, D. J. Hunter, et al. Polychlorinated Biphenyl Levels in Peripheral Blood and Non-Hodgkin's Lymphoma: A Report from Three Cohorts Cancer Res., June 1, 2007; 67(11): 5545 - 5552. [Abstract] [Full Text] [PDF]

				A. J. De Roos, P. Hartge, J. H. Lubin, J. S. Colt, S. Davis, J. R. Cerhan, R. K. Severson, W. Cozen, D. G. Patterson Jr., L. L. Needham, et al. Persistent Organochlorine Chemicals in Plasma and Risk of Non-Hodgkin's Lymphoma Cancer Res., December 1, 2005; 65(23): 11214 - 11226. [Abstract] [Full Text] [PDF]

				J. E. Muscat, J. A. Britton, M. V. Djordjevic, M. L. Citron, M. Kemeny, E. Busch-Devereaux, B. Pittman, and S. D. Stellman Adipose Concentrations of Organochlorine Compounds and Breast Cancer Recurrence in Long Island, New York Cancer Epidemiol. Biomarkers Prev., December 1, 2003; 12(12): 1474 - 1478. [Abstract] [Full Text] [PDF]

				K Teschke, A F Olshan, J L Daniels, A J De Roos, C G Parks, M Schulz, T L Vaughan, and H Kromhout Occupational exposure assessment in case-control studies: opportunities for improvement Occup. Environ. Med., September 1, 2002; 59(9): 575 - 594. [Abstract] [Full Text] [PDF]